Chengwei Capital
VC Fund
Shanghai, China
Chengwei Capital is a VC fund in Shanghai focused on Manufacturing and Software. Chengwei Ventures is a venture capital firm.
- Total investments:
- 110
- Last investment:
- Lead investor:
- 38%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Chengwei Capital invests in
Stages Chengwei Capital invests in
Countries Chengwei Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $8M–$25M
- Series A
- $2.8M–$57M
- Series B
- $8.5M–$55M
Investment Focus
Industry
- Manufacturing 14 (13%)
- Software 13 (12%)
- Internet 12 (11%)
- Information Technology 12 (11%)
- Health Care 8 (7%)
Stage
- Series A 28 (25%)
- Series B 28 (25%)
- Seed 15 (14%)
- Series C 12 (11%)
- Series D 7 (6%)
Country
- China 64 (58%)
- United States 9 (8%)
- Germany 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Pei Kang
Managing Director
|
Managing Director | Total investments: 4 | Find email | |
|
Dong Chengxian
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
|
Eric X Li
Founder, Managing Director
|
Founder, Managing Director | Total investments: 0 | Find email | |
|
Lou Qun
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Ping Ping
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Lingrui Zhixin Technology is an R&D company that specialises in full-stack, self-developed, domain-specific processors for intelligent computing applications. | Seed / Jul 10, 2026 | |
|
|
Full-Life Technologies Limited (“Full-Life”) is a fully integrated global RadioTherapeutics company headquartered in Shanghai, China with operations in Europe. | $109M / Series D / May 18, 2026 | |
|
|
Kington Laser specializes in the research, development, and manufacture of high-end laser processing equipment. | Venture - Series Unknown / Jan 07, 2026 | |
|
|
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. | $22M / Series A / Nov 13, 2025 | |
|
|
Full-Life Technologies Limited (“Full-Life”) is a fully integrated global RadioTherapeutics company headquartered in Shanghai, China with operations in Europe. | $50M / Series C / Sep 29, 2025 | |
|
|
Noshi Robotics is a company that manufactures planetary roller screws and associated actuator modules.It specializes in the design, fabrication, and manufacture of planetary roller screws and associated actuator modules. | Seed / Dec 03, 2024 | |
|
|
MEDSINGLONG is engaged in the medical equipment supply chain business. | Series A / Oct 25, 2024 | |
|
|
Tesseract Medical Research is a biotechnology and medical sciences business focused on delivering nutrition to meet unmet needs. | $20M / Seed / Jun 11, 2024 | |
|
|
LVSSN Group focuses on cross-border trade, retail, and wholesale business and is primarily involved in the supply of accessories, consumables, general equipment, spare parts, and other industrial supplies. The group also built its own MRO industrial products cross-border e-commerce service platform to assist domestic and foreign businesses inmodernizing their procurement processes digitally. | Seed / May 21, 2024 | |
|
|
Rapid Flex focuses on programmable SOCs (PSoCs) and offers adaptable computer-aided design approaches for a seamless chip design experience. They also offer domain-specific embedded FPGA (eFPGA) solutions for a variety of industrial, consumer, communication, and automotive applications. | Seed / Apr 17, 2024 | |
| See all 110 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chengwei Capital invest in?
Chengwei Capital invests primarily in Manufacturing, Software and Internet startups, most often at Series A and Series B stage. Most of the 110 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Chengwei Capital's check size?
Chengwei Capital typically joins rounds of $8M–$25M at Seed, $2.8M–$57M at Series A and $8.5M–$55M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chengwei Capital participates in.
How do I contact Chengwei Capital?
Public channels for Chengwei Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Chengwei Capital?
The team at Chengwei Capital includes Pei Kang (Managing Director), Dong Chengxian (Managing Director) and Eric X Li (Founder, Managing Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!